Target 80-100g daily minimum
Wu T, Zhang Y, Shi Y, et al
"Reactivate Your GLP-1" - Brand-stated marketing language from glpatch.shop
This gives athletes and support personnel sufficient time to make themselves aware of the changes, review any medications they use on Global DRO, and apply for a Therapeutic Use Exemption (TUE) if required before the updated List comes into effect on 1 January 2025
If chest pain persists beyond 48 hours, worsens despite conservative care, or develops new concerning features, schedule an urgent evaluation with your primary care physician or seek emergency department assessment
Key safety observations from available trial data include: Elevated resting heart rate in a dose-dependent manner Gastrointestinal adverse effects (nausea, vomiting, diarrhoea) as the most common side effects, consistent with the GLP-1 receptor agonist class [1] [3] No clinically significant QT interval prolongation was reported in available data, though the extent of formal thorough QT assessment has not been fully detailed in published sources
